SCHEMBL515169

SCHEMBL515169

CNC(CC(N)=O)C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ECE1 P42892 3/20 0.49
ITGB2 P05107 2/20 0.42
ICAM1 P05362 2/20 0.42
ITGAL P20701 2/20 0.42
CA2 P00918 4/20 0.40
CA1 P00915 3/20 0.40
ALDH1A1 P00352 2/20 0.40
RAB9A P51151 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
TGFBR1 P36897 1/20 0.39
KDM4E B2RXH2 2/20 0.36
MAPT P10636 2/20 0.36
PDCD1LG2 Q9BQ51 1/20 0.36
CD274 Q9NZQ7 1/20 0.36
THRB P10828 1/20 0.35
ALOX15 P16050 1/20 0.35
NFKB1 P19838 1/20 0.35
PTGS2 P35354 1/20 0.35
THPO P40225 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL160995 1.00 ECE1 (0.49) ECE1ITGB2ICAM1ITGALCA2
SCHEMBL160994 1.00 ECE1 (0.49) ECE1ITGB2ICAM1ITGALCA2
N-Methyl-D-Aspartic Acid (Nmda) SCHEMBL22186670 0.94 ECE1 (0.45) ECE1ITGB2ICAM1ITGALCA2
N-Methyl-D-Aspartic Acid (Nmda) SCHEMBL22186671 0.94 ECE1 (0.45) ECE1ITGB2ICAM1ITGALCA2
SCHEMBL21381486 0.85 ECE1 (0.45) ECE1ITGB2ICAM1ITGALCA2
1-Aminocyclopropane Carboxylic Acid SCHEMBL15741903 0.84 ECE1 (0.39) ECE1ITGB2ICAM1ITGALCA2
SCHEMBL24915343 0.83 ECE1 (0.44) ECE1ITGB2ICAM1ITGALCA2
SCHEMBL992852 0.83 ECE1 (0.44) ECE1ITGB2ICAM1ITGALCA2
SCHEMBL992850 0.83 ECE1 (0.44) ECE1ITGB2ICAM1ITGALCA2
SCHEMBL15866495 0.81 ECE1 (0.37) ECE1ITGB2ICAM1ITGALCA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 402 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12552839-B2 Cyclic peptides for protection against respiratory syncytial virus VIROMETIX AG (CH) 2026-02-17 US claimed
US-20250161408-A1 PEPTIDIC INHIBITORS OF AMYLOID SELF- AND CROSS-ASSEMBLY LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) 2025-05-22 US claimed
EP-4482852-A1 PEPTIDIC INHIBITORS OF AMYLOID SELF- AND CROSS-ASSEMBLY Technische Universität München (DE) 2025-01-01 EP claimed
EP-4464715-A2 BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NECTIN-4 BicycleTx Limited (GB) 2024-11-20 EP claimed
US-20240287143-A1 CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS Universität Zürich (CH) 2024-08-29 US claimed
EP-4295866-A2 CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS Virometix AG (CH) 2023-12-27 EP claimed
WO-2023161211-A1 PEPTIDIC INHIBITORS OF AMYLOID SELF- AND CROSS-ASSEMBLY Technische Universität München (DE) 2023-08-31 WO claimed
EP-3638284-B1 CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS VIROMETIX AG (CH) 2023-08-30 EP claimed
EP-4230645-A1 PEPTIDIC INHIBITORS OF AMYLOID SELF- AND CROSS-ASSEMBLY Technische Universität München (DE) 2023-08-23 EP claimed
US-11680085-B2 Cyclic peptides for protection against respiratory syncytial virus VIROMETIX AG (CH) 2023-06-20 US claimed
US-20080188079-A1 METAL-POLISHING COMPOSITION AND CHEMICAL MECHANICAL POLISHING METHOD BY USING THE SAME FUJIFILM CORPORATION (JP) 2008-08-07 US claimed
US-5843890-A Antibiotic GE 2270 factors B1, B2, C1, C2, D1, D2, E and T GRUPPO LEPETIT S.P.A. (IT) 1998-12-01 US claimed
US-5747295-A Antibiotic GE 2270 factors B1, B2, C1, C2, D1, D2, E and T GRUPPO LEPETIT S.P.A. (IT) 1998-05-05 US claimed
EP-0529410-B1 Antibiotic GE 2270 factor C2a BIOSEARCH ITALIA SPA (IT) 1998-02-25 EP claimed
US-5514649-A ANIMAL GROWTH REGULATORS; TREATING GRAMNEGATIVE AND GRAMPOSITIVE BACTERIAL INFECTIONS GRUPPO LEPETIT S.P.A. (IT) 1996-05-07 US claimed
EP-0451486-B1 Antibiotic GE 2270 factors B1, B2, C1, C2, D1, D2,E and T LEPETIT SPA (IT) 1995-04-19 EP claimed
EP-0529410-A2 Antibiotic GE 2270 factor C2a GRUPPO LEPETIT S.p.A. (IT) 1993-03-03 EP claimed
WO-1993000108-A1 NOVEL INHIBITORS OF PLATELET AGGREGATION CORVAS INTERNATIONAL, INC. (US) 1993-01-07 WO claimed
EP-0451486-A1 Antibiotic GE 2270 factors B1, B2, C1, C2, D1, D2,E and T GRUPPO LEPETIT S.p.A. (IT) 1991-10-16 EP claimed
EP-0410539-A1 Fibrinogen receptor antagonists MERCK & CO. INC. (US) 1991-01-30 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11680085-B2 Cyclic peptides for protection against respiratory syncytial virus VIP, LNPEP, CSTB ECE1 1396/4885ITGB2 4810/4885ICAM1 1496/4885
US-20240287143-A1 CYCLIC PEPTIDES FOR PROTECTION AGAINST RESPIRATORY SYNCYTIAL VIRUS VIP, QPCT, QPCTL ECE1 1992/4885ITGB2 4786/4885ICAM1 2986/4885
US-12552839-B2 Cyclic peptides for protection against respiratory syncytial virus CTH, VIP, CXCL10 ECE1 605/4885ITGB2 4390/4885ICAM1 3204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.